In this cohort of 27 patients with PD-L1 expression of at least 1% in the primary NSCLC, in whom systemic and central nervous system responses could be evaluated, six patients were found to have discordant responses in BM versus the primary lung tumor burden.8 Here, CD274 is linked to non-small cell lung carcinoma.